Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06118567

Effect of Nitrous Oxide on Aggression.

Nitrous Oxide and Cortico-Limbic Function in Aggression

Sponsor: National Institute of Mental Health (NIMH)

Conditions Intermittent Explosive Disorder

Updated 4 times since 2023 Last updated: Mar 26, 2025 Started: Sep 6, 2022 Primary completion: Aug 31, 2027 Completion: Aug 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Intermittent Explosive Disorder, this trial is actively recruiting participants. The trial is conducted by National Institute of Mental Health (NIMH) and has accumulated 4 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Apr 2025 — Present [monthly]

Recruiting PHASE2
Sep 2024 — Apr 2025 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Dec 2023 — Jul 2024 [monthly]

Recruiting PHASE2

First recorded

Sep 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Mental Health (NIMH)
Ohio State University

Data source: Ohio State University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Columbus, United States